HAMLET (human α-lactalbumin made lethal to tumor cells) triggers autophagic tumor cell death
✍ Scribed by Sonja Aits; Lotta Gustafsson; Oskar Hallgren; Patrick Brest; Mattias Gustafsson; Maria Trulsson; Ann-Kristin Mossberg; Hans-Uwe Simon; Baharia Mograbi; Catharina Svanborg
- Book ID
- 102862703
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- French
- Weight
- 751 KB
- Volume
- 124
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
HAMLET, a complex of partially unfolded α‐lactalbumin and oleic acid, kills a wide range of tumor cells. Here we propose that HAMLET causes macroautophagy in tumor cells and that this contributes to their death. Cell death was accompanied by mitochondrial damage and a reduction in the level of active mTOR and HAMLET triggered extensive cytoplasmic vacuolization and the formation of double‐membrane‐enclosed vesicles typical of macroautophagy. In addition, HAMLET caused a change from uniform (LC3‐I) to granular (LC3‐II) staining in LC3‐GFP‐transfected cells reflecting LC3 translocation during macroautophagy, and this was blocked by the macroautophagy inhibitor 3‐methyladenine. HAMLET also caused accumulation of LC3‐II detected by Western blot when lysosomal degradation was inhibited suggesting that HAMLET caused an increase in autophagic flux. To determine if macroautophagy contributed to cell death, we used RNA interference against Beclin‐1 and Atg5. Suppression of Beclin‐1 and Atg5 improved the survival of HAMLET‐treated tumor cells and inhibited the increase in granular LC3‐GFP staining. The results show that HAMLET triggers macroautophagy in tumor cells and suggest that macroautophagy contributes to HAMLET‐induced tumor cell death. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract We studied if bladder cancers respond to HAMLET (human α‐lactalbumin made lethal to tumor cells) to establish if intravesical HAMLET application might be used to selectively remove cancer cells __in vivo__. Patients with nonmuscle invasive transitional cell carcinomas were included. Nin